|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K2039/507 | (2013.01) | ||
| C12P 21/08 | (2006.01) | ||
| C07K 16/2887 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/734 | (2013.01) | ||
| C07K2317/77 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 2477648 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10817793.2 |
| Date of filing the European patent application | 2010-09-15 | |
| (97) | Date of publication of the European application | 2012-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/048992 |
| Date | 2010-09-15 |
| (87) | Number | WO 2011/034969 |
| Date | 2011-03-24 |
| (30) | Number | Date | Country code |
| 276726 P | 2009-09-15 | US |
| (72) |
WEISSMAN, Irving L. , US
MAJETI, Ravindra , US
ALIZADEH, Arash Ash , US
CHAO, Mark P. , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS |
| SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS |